Parcion Private Wealth’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.06M Sell
31,110
-187
-0.6% -$38.8K 0.34% 59
2026
Q1
$7.03M Sell
31,297
-835
-3% -$208K 0.44% 44
2025
Q4
$7.74M Sell
32,132
-900
-3% -$230K 0.47% 42
2025
Q3
$9.04M Sell
33,032
-489
-1% -$134K 0.56% 36
2025
Q2
$8.65M Buy
33,521
+262
+0.8% +$62.5K 0.62% 36
2025
Q1
$7.45M Buy
33,259
+1,044
+3% +$244K 0.61% 41
2024
Q4
$7.37M Buy
32,215
+302
+0.9% +$72.7K 0.56% 41
2024
Q3
$7.79M Buy
31,913
+1,178
+4% +$263K 0.65% 33
2024
Q2
$5.88M Sell
30,735
-1,410
-4% -$286K 0.54% 40
2024
Q1
$6.37M Buy
32,145
+476
+2% +$87.2K 0.56% 36
2023
Q4
$5.45M Buy
+31,669
New +$4.87M 0.5% 42

Other funds holding RMD

Parcion Private Wealth's RMD Position: Q2 2026 in Review

Parcion Private Wealth reduced its ResMed (RMD) stake by 0.6% in Q2 2026, selling an estimated $38.8K and leaving 31,110 shares worth $6.06M. The position accounts for 0.34% of the portfolio, ranked #59.

Parcion Private Wealth first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.04M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Parcion Private Wealth held 31,110 shares of ResMed worth $6.06M as of Q2 2026.
  • Parcion Private Wealth sold 187 ResMed shares in Q2 2026, an estimated $38.8K.
  • ResMed made up 0.34% of Parcion Private Wealth's portfolio in Q2 2026, its #59 holding.
  • Parcion Private Wealth first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Parcion Private Wealth's ResMed position peaked at $9.04M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Parcion Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.